Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patients.

ABSTRACT:

Background

Veno-venous extracorporeal membrane oxygenation (V-V ECMO) support is increasingly used in the management of COVID-19-related acute respiratory distress syndrome (ARDS). However, the clinical decision-making to initiate V-V ECMO for severe COVID-19 still remains unclear. In order to determine the optimal timing and patient selection, we investigated the outcomes of both COVID-19 and non-COVID-19 patients undergoing V-V ECMO support.

Methods

Overall, 138 patients were included in this study. Patients were stratified into two cohorts: those with COVID-19 and non-COVID-19 ARDS.

Results

The survival in patients with COVID-19 was statistically similar to non-COVID-19 patients (p = .16). However, the COVID-19 group demonstrated higher rates of bleeding (p = .03)

SUBMITTER: Kurihara C 

PROVIDER: S-EPMC8653196 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature